4549 Eiken Kagaku
Jul 5, 2025
1 min read
A major clinical diagnostics company. Has 70% market share in fecal occult blood test reagents (FIT). Also developing urine tests and genetic tests.
A major clinical diagnostics company. Has 70% market share in fecal occult blood test reagents (FIT). Also developing urine tests and genetic tests.
Comments